Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Cash from Investing Activities
Zymeworks Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Cash from Investing Activities
-$207.3m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Investing Activities
$78m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Investing Activities
-$42.8m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-107%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Investing Activities
-$6.7m
|
CAGR 3-Years
65%
|
CAGR 5-Years
-149%
|
CAGR 10-Years
-67%
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Investing Activities
-CA$185k
|
CAGR 3-Years
15%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Sunshine Biopharma Inc
OTC:SBFM
|
Cash from Investing Activities
-$656.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-131%
|
CAGR 10-Years
N/A
|
See Also
What is Zymeworks Inc's Cash from Investing Activities?
Cash from Investing Activities
-207.3m
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Cash from Investing Activities amounts to -207.3m USD.
What is Zymeworks Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-14%
Over the last year, the Cash from Investing Activities growth was -285%. The average annual Cash from Investing Activities growth rates for Zymeworks Inc have been -68% over the past three years , -14% over the past five years .